GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,233,000 | -2.4% | 51,303 | -2.3% | 0.01% | -26.3% |
| Q1 2022 | $2,287,000 | +178.2% | 52,510 | +181.6% | 0.02% | +137.5% |
| Q4 2021 | $822,000 | -37.7% | 18,645 | -46.0% | 0.01% | -52.9% |
| Q3 2021 | $1,319,000 | -18.6% | 34,507 | -15.2% | 0.02% | -5.6% |
| Q2 2021 | $1,620,000 | -54.4% | 40,673 | -59.1% | 0.02% | -60.0% |
| Q1 2021 | $3,552,000 | +24.2% | 99,536 | +28.1% | 0.04% | +15.4% |
| Q4 2020 | $2,859,000 | +24.1% | 77,680 | +27.0% | 0.04% | +14.7% |
| Q3 2020 | $2,303,000 | +226.7% | 61,185 | +253.9% | 0.03% | +183.3% |
| Q2 2020 | $705,000 | +126.0% | 17,289 | +110.1% | 0.01% | +50.0% |
| Q1 2020 | $312,000 | +6.8% | 8,227 | +32.5% | 0.01% | +60.0% |
| Q4 2019 | $292,000 | +5.4% | 6,207 | -4.2% | 0.01% | -16.7% |
| Q3 2019 | $277,000 | -84.6% | 6,482 | -85.6% | 0.01% | -81.8% |
| Q2 2019 | $1,797,000 | -29.3% | 44,911 | -26.2% | 0.03% | -59.8% |
| Q1 2019 | $2,543,000 | +811.5% | 60,844 | +734.1% | 0.08% | +530.8% |
| Q4 2018 | $279,000 | -61.5% | 7,295 | -59.5% | 0.01% | -67.5% |
| Q3 2018 | $724,000 | -65.2% | 18,028 | -65.1% | 0.04% | -61.9% |
| Q2 2018 | $2,083,000 | +400.7% | 51,671 | +385.0% | 0.10% | +337.5% |
| Q1 2018 | $416,000 | -71.8% | 10,654 | -70.6% | 0.02% | -70.7% |
| Q3 2017 | $1,473,000 | +210.8% | 36,285 | +229.9% | 0.08% | +173.3% |
| Q2 2017 | $474,000 | -35.0% | 11,000 | -36.4% | 0.03% | -42.3% |
| Q1 2017 | $729,000 | -46.8% | 17,296 | -51.4% | 0.05% | -52.3% |
| Q4 2016 | $1,370,000 | +155.1% | 35,584 | +185.8% | 0.11% | +211.4% |
| Q3 2016 | $537,000 | -33.0% | 12,452 | -32.7% | 0.04% | -25.5% |
| Q2 2016 | $802,000 | +102.0% | 18,511 | +89.1% | 0.05% | +104.3% |
| Q1 2016 | $397,000 | -60.8% | 9,790 | -61.1% | 0.02% | -61.0% |
| Q4 2015 | $1,014,000 | +60.2% | 25,139 | +52.6% | 0.06% | +84.4% |
| Q3 2015 | $633,000 | -82.9% | 16,470 | -81.4% | 0.03% | -82.2% |
| Q2 2015 | $3,691,000 | +914.0% | 88,609 | +1023.3% | 0.18% | +900.0% |
| Q1 2015 | $364,000 | -43.3% | 7,888 | -47.5% | 0.02% | -48.6% |
| Q4 2014 | $642,000 | +15.1% | 15,023 | +23.9% | 0.04% | +2.9% |
| Q3 2014 | $558,000 | +52.9% | 12,129 | +77.7% | 0.03% | +54.5% |
| Q2 2014 | $365,000 | – | 6,824 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |